|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.770 USD | -1.88% |
|
-5.71% | -60.18% |
| 16/05 | Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says | MT |
| 29/04 | Wave Life Sciences Ltd., Q1 2026 Earnings Call, Apr 28, 2026 |
| Capitalization | 130.26Cr 112.09Cr 102.48Cr 98Cr 179.25Cr 12TCr 182.22Cr 1.23TCr 475.77Cr 5.93TCr 488.83Cr 478.35Cr 21TCr | P/E ratio 2026 * |
-7.38x | P/E ratio 2027 * | -5.88x |
|---|---|---|---|---|---|
| Enterprise value | 94Cr 81Cr 74Cr 70Cr 128.97Cr 8.99TCr 131.1Cr 884.62Cr 342.31Cr 4.27TCr 351.7Cr 344.16Cr 15TCr | EV / Sales 2026 * |
16.4x | EV / Sales 2027 * | 22.6x |
| Free-Float |
84.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Wave Life Sciences Ltd.
| 1 day | -1.88% | ||
| 1 week | -5.71% | ||
| Current month | -4.11% | ||
| 1 month | -10.80% | ||
| 3 months | -46.61% | ||
| 6 months | -4.38% | ||
| Current year | -60.18% |
| 1 week | 6.67 |  | 7.36 |
| 1 month | 6.67 | | 7.68 |
| Current year | 5.02 | | 19.5 |
| 1 year | 5.02 | | 21.73 |
| 3 years | 3.15 | | 21.73 |
| 5 years | 1.16 | | 21.73 |
| 10 years | 1.16 | | 56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 52 | 01/12/2013 |
Kyle Moran
DFI | Director of Finance/CFO | 56 | 01/07/2014 |
| Chief Tech/Sci/R&D Officer | 60 | 28/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Bolno
BRD | Director/Board Member | 52 | 01/12/2013 |
Peter Kolchinsky
BRD | Director/Board Member | 49 | 01/01/2015 |
Gregory Verdine
BRD | Director/Board Member | 66 | 01/07/2013 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.88% | -5.71% | +7.46% | +67.99% | 132.76Cr | |
| -0.14% | +3.34% | +42.69% | +84.71% | 5.04TCr | |
| +0.12% | -3.44% | +67.99% | +49.40% | 4.6TCr | |
| -5.60% | +7.69% | +62.36% | +466.37% | 2.51TCr | |
| -2.65% | -4.86% | -3.02% | -17.01% | 2.33TCr | |
| +3.19% | +3.12% | +41.22% | -27.18% | 1.72TCr | |
| -1.66% | +2.59% | +30.04% | -41.59% | 1.62TCr | |
| -2.91% | -10.30% | +47.85% | +186.19% | 1.46TCr | |
| -7.00% | -6.69% | -26.94% | +821.86% | 1.41TCr | |
| +0.41% | -2.37% | +40.93% | - | 1.29TCr | |
| Average | -1.81% | -2.80% | +31.06% | +176.75% | 2.21TCr | |
| Weighted average by Cap. | -1.42% | -1.44% | +39.93% | +149.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.73Cr 4.93Cr 4.51Cr 4.3Cr 7.88Cr 549.51Cr 8.01Cr 54Cr 21Cr 260.86Cr 21Cr 21Cr 908.82Cr | 5.15Cr 4.43Cr 4.05Cr 3.87Cr 7.09Cr 494.23Cr 7.21Cr 49Cr 19Cr 234.61Cr 19Cr 19Cr 817.39Cr |
| Net income | -18Cr -16Cr -15Cr -14Cr -25Cr -1.77TCr -26Cr -174.3Cr -67Cr -840.97Cr -69Cr -68Cr -2.93TCr | -24Cr -21Cr -19Cr -18Cr -34Cr -2.34TCr -34Cr -229.98Cr -89Cr -1.11TCr -91Cr -89Cr -3.87TCr |
| Net Debt | -37Cr -31Cr -29Cr -27Cr -50Cr -3.51TCr -51Cr -344.91Cr -133.47Cr -1.66TCr -137.13Cr -134.19Cr -5.8TCr | -14Cr -12Cr -11Cr -11Cr -19Cr -1.34TCr -20Cr -132.06Cr -51Cr -637.17Cr -53Cr -51Cr -2.22TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 6.770 $ | -1.88% | 42,25,763 |
| 14/26/14 | 6.900 $ | -1.29% | 31,69,551 |
| 13/26/13 | 6.990 $ | +2.95% | 73,05,725 |
| 12/26/12 | 6.790 $ | -3.96% | 49,98,664 |
| 11/26/11 | 7.070 $ | -1.53% | 30,09,380 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WVE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition